Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Histogen Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 23 | 10 | −13 |
| SharesConverted for a 1-for-20 split | 200.4K | 100.6K | −99.8K (−49.8%) |
| Value | $1.00M | $229.0K | −$772.0K (−77.1%) |
New holders (3)
Institutions that held Histogen Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Prudential Financial Inc | 13,000 | $30.0K | 0.00% |
| HRT Financial LP | 11,356 | $26.0K | 0.00% |
| Citadel Advisors LLC | 10,551 | $24.0K | 0.00% |
Sold out (16)
Institutions that held Histogen Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Renaissance Technologies LLC | 1,167,067 | $292.0K |
| State Street Corp | 172,200 | $43.0K |
| Susquehanna International Group, LLP | 155,439 | $39.0K |
| Millennium Management LLC | 95,097 | $24.0K |
| UBS Group AG | 97,044 | $24.0K |
| Northern Trust Corp | 90,026 | $23.0K |
| Virtu Financial LLC | 92,228 | $23.0K |
| United Capital Financial Advisers, LLC | 79,987 | $20.0K |
| Synovus Financial Corp | 51,000 | $13.0K |
| Newman Dignan & Sheerar, Inc. | 52,522 | $13.0K |
| Tower Research Capital LLC (TRC) | 33,127 | $8.00K |
| Two Sigma Advisers, LP | 14,600 | $4.00K |
| Bank of America Corp | 3 | $0 |
| FMR LLC | 100 | $0 |
| Morgan Stanley | 2,177 | $0 |
| Compagnie Lombard Odier SCmA | 300 | $0 |